• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCoronavirus

Twin Omicron subvariants have taken over the U.S., but they’re not quite identical. One is ‘the worst version of the virus we’ve seen’

By
Erin Prater
Erin Prater
Down Arrow Button Icon
By
Erin Prater
Erin Prater
Down Arrow Button Icon
June 28, 2022, 11:12 AM ET
U.S. President Joe Biden greets children at a COVID-19 vaccination clinic at the Church of the Holy Communion in Washington, D.C., on June 21.
U.S. President Joe Biden greets children at a COVID-19 vaccination clinic at the Church of the Holy Communion in Washington, D.C., on June 21.Nicholas Kamm / AFP via Getty Images

A pair of immune-evading Omicron subvariants are now dominant in the U.S., having overtaken so-called “stealth Omicron” and close relative BA.2.12.1 in mere weeks, according to federal health data released Tuesday.

BA.4 and BA.5, which swept South Africa this spring thanks to their ability to evade immunity, were estimated to have caused slightly more than half (52%) of COVID infections in the U.S. last week, according to new data from the U.S. Centers for Disease Control and Prevention.

“The Omicron subvariant BA.5 is the worst version of the virus that we’ve seen,” Dr. Eric Topol, a professor of molecular medicine at Scripps Research and founder and director of the Scripps Research Translational Institute, wrote Monday in anticipation of the viral coup.

“It takes immune escape, already extensive, to the next level, and, as a function of that, enhanced transmissibility,” well beyond what has been seen before, he wrote. “You could say it’s not so bad because there hasn’t been a marked rise in hospitalizations and deaths as we saw with Omicron, but that’s only because we had such a striking adverse impact from Omicron, for which there is at least some cross-immunity.”

BA.2.12.1, another Omicron subvariant dominant before the advent of BA.4 and BA.5, was responsible for 42% of cases. So-called stealth Omicron, BA.2, nicknamed for its ability to evade detection on PCR tests, came in third, comprising nearly 6% of cases. It had been dominant in the U.S. until BA.2.12.1 overtook it last month.

The jury is still out on whether current vaccines hold up against BA.5. But given that vaccines experienced an approximate 15% drop in protection against severe disease from Delta to Omicron, “it would not be at all surprising to me to see further decline of protection against hospitalizations and deaths,” Topol wrote.

BA.4 and BA.5 were first detected in the U.S. in late March, as Fortune previously reported. The variants, discovered in South Africa, quickly took hold in the country in April and May despite the fact that almost all South Africans had been vaccinated or previously had COVID by that point.

The pair of variants are quickly taking hold globally. But their rise is often masked because in many countries, it’s occurring at the same time as a decline in BA.2 infections, Topol wrote. This can lead to the appearance of a sustained wave when, in reality, dual waves are present—the first from an older version of Omicron, and the second from BA.4/BA.5.

A recent study out of South Africa found that those who had been previously infected with Omicron but not vaccinated experienced a nearly eightfold drop in neutralizing antibodies when exposed to BA.4 and BA.5. Those who had been vaccinated and previously infected with Omicron saw a milder threefold decrease. 

Alex Sigal, a professor at the Africa Health Research Institute in South Africa, told Fortune in May that symptoms of the new subvariants are similar to typical Omicron symptoms, which include fever, loss of smell, and malaise. 

“I haven’t seen early symptoms of respiratory distress, the major COVID-specific symptom that makes this disease so dangerous,” he said. “It doesn’t feel nice, but there’s less chance of dying.”

Sign up for the Fortune Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.

About the Author
By Erin Prater
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

Netflix cofounder Marc Randolph
Successlifestyle
Netflix cofounder says he stopped work at 5 p.m. every Tuesday for 30 years to stay ‘sane,’ no matter the crisis: ‘Nothing got in the way of that’
By Emma BurleighApril 5, 2026
8 hours ago
peeps in yellow dye on a conveyor belt
HealthFood and drink
‘No one is saying, ‘I want more cancer with my candy”: Why Peeps are a ‘food chemical success story’ despite RFK Jr’s campaign to destroy their dyes
By Catherina GioinoApril 5, 2026
8 hours ago
6 Best Vitamins to Boost Energy (2026): Top Recommendations From Experts
HealthDietary Supplements
6 Best Vitamins to Boost Energy (2026): Top Recommendations From Experts
By Emily PharesApril 3, 2026
2 days ago
A person taking a supplement.
HealthDietary Supplements
What Is NMN: Everything You Need to Know From Experts
By Katherine Van DisApril 3, 2026
2 days ago
Hers Hair Loss Minoxidil
HealthDietary Supplements
Hers Hair Growth Review 2026: Pros, Cons, and More From Hands-On Testing
By Emily PharesApril 3, 2026
2 days ago
The Benefits of Red Light Therapy: Expert-Approved Advice
HealthHealth
The Benefits of Red Light Therapy: Expert-Approved Advice
By Katherine Van DisApril 3, 2026
2 days ago

Most Popular

The World Cup is supposed to be an economic windfall. But 'you're seeing a number of headwinds' now
North America
The World Cup is supposed to be an economic windfall. But 'you're seeing a number of headwinds' now
By Fortune EditorsApril 4, 2026
1 day ago
'It’s shocking how poorly prepared the administration is': DOGE gutted major energy personnel who warn the U.S. has lost key insights amid Iran war
Energy
'It’s shocking how poorly prepared the administration is': DOGE gutted major energy personnel who warn the U.S. has lost key insights amid Iran war
By Fortune EditorsApril 5, 2026
11 hours ago
Major 4-day workweek study suggests that when we work 5 days we spend one doing basically nothing
Success
Major 4-day workweek study suggests that when we work 5 days we spend one doing basically nothing
By Fortune EditorsApril 2, 2026
3 days ago
Meet a 74-year-old New Yorker who unretired to become an Uber driver: 'I'm amazed at what people will tell me'
Personal Finance
Meet a 74-year-old New Yorker who unretired to become an Uber driver: 'I'm amazed at what people will tell me'
By Fortune EditorsApril 4, 2026
1 day ago
College grads in ‘AI-proof’ careers like psychology and education are seeing negative returns on their degrees
Personal Finance
College grads in ‘AI-proof’ careers like psychology and education are seeing negative returns on their degrees
By Fortune EditorsApril 4, 2026
1 day ago
A Yale economist says AGI won't automate most jobs—because they're not worth the trouble
AI
A Yale economist says AGI won't automate most jobs—because they're not worth the trouble
By Fortune EditorsApril 4, 2026
1 day ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.